SPX4,026.12-1.14 -0.03%
DIA343.52+1.57 0.46%
IXIC11,226.36-58.96 -0.52%

--BTIG Adjusts CASI Pharmaceuticals' Price Target to $10 From $21, Keeps Buy Rating

--BTIG Adjusts CASI Pharmaceuticals' Price Target to $10 From $21, Keeps Buy Rating

MT Newswires · 11/16/2022 04:39

Please log in to view news